This is a preview. View original post on this site
The 5th U.S. Circuit Court of Appeals on May 15 temporarily blocked a March district court ruling that jeopardized cost-sharing required by the Affordable Care Act for preventive care, including cancer screenings and PrEP, an HIV-prevention drug.
